** Shares of medical device maker Inogen rise 10.6% to $9.49 premarket
** Co says its device for clearing mucus from lungs has received FDA 510(k) approval
** FDA 510(k) approval is a process where a medical device is shown to be safe and similar to an existing device before it can be sold
** The device, SIMEOX 200 Airway Clearance Device, helps improve bronchial drainage in patients with chronic respiratory diseases - INGN
** The device is intended for patients who can cough on their own - INGN
** Co plans a limited launch of the device at targeted sites in 2025
** As of last close, stock has risen 56.3% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.